Earnings History Data for NeuroMetrix, Inc. (NURO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
NeuroMetrix, Inc.
Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-08-2024 | PM | NURO | NeuroMetrix, Inc. | 7.10 | -0.74 | 0.00 | -1.52 | NeuroMetrix GAAP EPS of -$0.74, revenue of $0.8M [8/6/2024 7:25 AM] |
3.16 | -0.38 (-10.73%) |
0.0 | 0.0 (0.00%) |
2.70 - 7.19 | 91,978 | 20,000 | 0 | ||
| 22-02-2024 | PM | NURO | NeuroMetrix, Inc. | 3.72 | -1.43 | 0.00 | -0.72 | NeuroMetrix GAAP EPS of -$1.43, revenue of $1.32B [2/22/2024 7:09 AM] |
2.91 | -0.26 (-8.20%) |
3.30 | 0.13 (4.10%) |
2.70 - 15.04 | 208,964 | 70,000 | 3,017 | ||
| 26-10-2023 | PM | NURO | NeuroMetrix, Inc. | 5.59 | -0.21 | 0.00 | -0.23 | NeuroMetrix reports Q3 results [10/26/2023 7:04 AM] |
0.5401 | -0.13 (-19.10%) |
0.60 | -0.07 (-10.13%) |
0.47 - 2.18 | 212,283 | 10,000 | 22,347 | ||
| 27-07-2023 | PM | NURO | NeuroMetrix, Inc. | 7.67 | -0.19 | 0.00 | -0.17 | NeuroMetrix GAAP EPS of -$0.19, revenue of $1.66M [7/27/2023 7:08 AM] |
0.91 | -0.07 (-6.97%) |
1.00 | 0.02 (2.23%) |
0.89 - 4.73 | 71,274 | 50,000 | 2,464 | ||
| 03-05-2023 | PM | 7:00 AM ET (May 3) |
NURO | NeuroMetrix, Inc. | 10.67 | -0.20 | 0.00 | -0.14 | NeuroMetrix GAAP EPS of -$0.20, revenue of $1.7M [5/3/2023 7:24 AM] |
1.02 | -0.37 (-26.62%) |
1.17 | -0.22 (-15.83%) |
0.97 - 5.89 | 317,072 | 20,000 | 21,809 | |
| 23-02-2023 | PM | 7:00 AM ET (Feb 23) |
NURO | NeuroMetrix, Inc. | 13.96 | -0.09 | 0.00 | -0.15 | NeuroMetrix GAAP EPS of -$0.09, revenue of $1.84N [2/23/2023 7:16 AM] |
1.79 | 0.09 (5.29%) |
1.80 | 0.10 (5.88%) |
1.33 - 5.89 | 23,246 | 40,000 | 740 | |
| 20-10-2022 | PM | 7:00 AM ET (Oct 20) |
NURO | NeuroMetrix, Inc. | 15.76 | -0.23 | 0.00 | -0.12 | NeuroMetrix reports Q3 results [10/20/2022 7:04 AM] |
1.88 | -0.23 (-10.90%) |
1.99 | -0.12 (-5.69%) |
1.86 - 9.49 | 149,007 | 1,890,000 | 21,564 | |
| 21-07-2022 | PM | 7:00 AM ET (Jul 21) |
NURO | NeuroMetrix, Inc. | 26.52 | -0.17 | 0.00 | -0.13 | NeuroMetrix GAAP EPS of -$0.17, revenue of $2.1M [7/21/2022 7:07 AM] |
3.65 | -0.21 (-5.35%) |
3.73 | -0.13 (-3.37%) |
2.70 - 38.75 | 78,996 | 60,000 | 6,879 | |
| 26-04-2022 | PM | 7:00 AM ET (Apr 26) |
NURO | NeuroMetrix, Inc. | 27.55 | -0.14 | 0.00 | -0.02 | NeuroMetrix GAAP EPS of -$0.14, revenue of $2.3M [4/26/2022 7:11 AM] |
3.34 | -0.41 (-10.93%) |
3.69 | -0.06 (-1.60%) |
2.58 - 38.75 | 132,506 | 100,000 | 6,104 | |
| 27-01-2022 | PM | 7:00 AM ET (Jan 27) |
NURO | NeuroMetrix, Inc. | 30.31 | -0.15 | 0.00 | -0.05 | NeuroMetrix reports Q4 results [1/27/2022 7:06 AM] |
4.09 | -0.33 (-7.49%) |
4.43 | 0.01 (0.23%) |
2.58 - 38.75 | 215,275 | 7,010,000 | 1,729 | |
| 21-10-2021 | PM | 7:00 AM ET (Oct 21) |
NURO | NeuroMetrix, Inc. | 51.00 | -0.12 | 0.00 | -0.07 | NeuroMetrix reports Q3 results [10/21/2021 7:14 AM] |
8.34 | -0.76 (-8.40%) |
8.62 | -0.48 (-5.27%) |
1.47 - 38.75 | 815,007 | 1,150,000 | 75,590 | |
|
||||||||||||||||||
| 22-07-2021 | PM | 7:00 AM ET (Jul 22) |
NURO | NeuroMetrix, Inc. | 49.66 | -0.13 | 0.00 | -0.28 | NeuroMetrix reports Q2 results [7/22/2021 7:08 AM] |
24.90 | 4.10 (19.72%) |
38.49 | 17.69 (85.05%) |
1.39 - 38.75 | 48,223,008 | 37,190,000 | 12,526,461 | |
|
||||||||||||||||||
| 22-04-2021 | PM | 7:00 AM ET (Apr 22) |
NURO | NeuroMetrix, Inc. | 12.00 | -0.02 | 0.00 | -0.45 | NeuroMetrix reports Q1 results [4/22/2021 7:04 AM] |
2.95 | -0.08 (-2.64%) |
0.0 | 0.0 (0.00%) |
1.39 - 5.78 | 95,752 | 60,000 | 0 | |
| 28-01-2021 | PM | 7:00 AM ET (Jan 28) |
NURO | NeuroMetrix, Inc. | 18.85 | -0.05 | 0.00 | 0.00 | NeuroMetrix reports Q4 results [1/28/2021 9:02 AM] |
3.93 | -0.47 (-10.68%) |
4.11 | -0.29 (-6.59%) |
0.81 - 6.20 | 483,415 | 849,068 | 20,445 | |
| 22-10-2020 | PM | 7:00 AM ET (Oct 22) |
NURO | NeuroMetrix, Inc. | 6.40 | -0.07 | 0.00 | -1.40 | NeuroMetrix reports Q3 results [10/22/2020 7:11 AM] |
1.60 | -0.04 (-2.44%) |
1.69 | 0.05 (3.06%) |
0.81 - 6.20 | 139,470 | 269,329 | 14,915 | |
|
|
||||||||||||||||||